help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, L.
Right arrow Articles by Brunner, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, L.
Right arrow Articles by Brunner, G.
(American Journal of Pathology. 1999;154:105-111.)
© 1999 American Society for Investigative Pathology


Technical Advances

Active Transforming Growth Factor-ß in Wound Repair

Determination Using a New Assay

Liju Yang, Cindy X. Qiu, Anna Ludlow, Mark W. J. Ferguson and Georg Brunner

From the Division of Cells, Immunology and Development, School of Biological Sciences, University of Manchester, Manchester, United Kingdom

Transforming growth factor (TGF)-ß regulates wound repair and scarring in an isoform-specific fashion. TGF-ß is produced in a latent form, and its activation is a critical regulatory step controlling the bioactivity of this growth factor. To date, it has been impossible to determine latent TGF-ß activation in vivo due to a lack of quantitative assays. We describe here a semiquantitative modification of the plasminogen activator inhibitor-1/luciferase bioassay (PAI/L assay) for TGF-ß, which we used to determine active and latent TGF-ß isoforms in frozen sections of rat wound tissue. We found that significant amounts of latent TGF-ß were rapidly activated upon wounding (38% of the total TGF-ß at 1 hour after wounding). A second peak of active TGF-ß (17% of total) occurred at 5 days after wounding. The predominant isoforms were TGF-ß1 and -2 with only minor amounts of TGF-ß3 present. This is the first TGF-ß bioassay allowing semiquantitative determination of active and latent isoforms present in vivo, and our results document the significance and temporal regulation of latent TGF-ß isoform activation in wound repair.





This article has been cited by other articles:


Home page
J R Soc InterfaceHome page
B. D. Cumming, D. L. S. McElwain, and Z. Upton
A mathematical model of wound healing and subsequent scarring
J R Soc Interface, January 6, 2010; 7(42): 19 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
A. Eslami, C. L. Gallant-Behm, D. A. Hart, C. Wiebe, D. Honardoust, H. Gardner, L. Hakkinen, and H. S. Larjava
Expression of Integrin {alpha}v{beta}6 and TGF-{beta} in Scarless vs Scar-forming Wound Healing
J. Histochem. Cytochem., June 1, 2009; 57(6): 543 - 557.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
P.-J. Wipff, D. B. Rifkin, J.-J. Meister, and B. Hinz
Myofibroblast contraction activates latent TGF- 1 from the extracellular matrix
J. Cell Biol., December 17, 2007; 179(6): 1311 - 1323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. A. Gorvy, S. E. Herrick, M. Shah, and M. W.J. Ferguson
Experimental Manipulation of Transforming Growth Factor-{beta} Isoforms Significantly Affects Adhesion Formation in a Murine Surgical Model
Am. J. Pathol., October 1, 2005; 167(4): 1005 - 1019.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. O. Yee, M. Streit, T. Hawighorst, M. Detmar, and J. Lawler
Expression of the Type-1 Repeats of Thrombospondin-1 Inhibits Tumor Growth Through Activation of Transforming Growth Factor-{beta}
Am. J. Pathol., August 1, 2004; 165(2): 541 - 552.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Hakkinen, L. Koivisto, H. Gardner, U. Saarialho-Kere, J. M. Carroll, M. Lakso, H. Rauvala, M. Laato, J. Heino, and H. Larjava
Increased Expression of {beta}6-Integrin in Skin Leads to Spontaneous Development of Chronic Wounds
Am. J. Pathol., January 1, 2004; 164(1): 229 - 242.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. WERNER and R. GROSE
Regulation of Wound Healing by Growth Factors and Cytokines
Physiol Rev, July 1, 2003; 83(3): 835 - 870.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Wang, N. Shiota, M. J. Leskinen, K. A. Lindstedt, and P. T. Kovanen
Mast Cell Chymase Inhibits Smooth Muscle Cell Growth and Collagen Expression In Vitro: Transforming Growth Factor-{beta}1-Dependent and -Independent Effects
Arterioscler Thromb Vasc Biol, December 1, 2001; 21(12): 1928 - 1933.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Yang, T. Chan, J. Demare, T. Iwashina, A. Ghahary, P. G. Scott, and E. E. Tredget
Healing of Burn Wounds in Transgenic Mice Overexpressing Transforming Growth Factor-{beta}1 in the Epidermis
Am. J. Pathol., December 1, 2001; 159(6): 2147 - 2157.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. A. LINDSTEDT, Y. WANG, N. SHIOTA, J. SAARINEN, M. HYYTIAINEN, J. O. KOKKONEN, J. KESKI-OJA, and P. T. KOVANEN
Activation of paracrine TGF-{beta}1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase
FASEB J, June 1, 2001; 15(8): 1377 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Chamberlain, J. Gunn, S. E. Francis, C. M. Holt, N. D. Arnold, D. C. Cumberland, M. W.J. Ferguson, and D. C. Crossman
TGF{beta} is active, and correlates with activators of TGF{beta}, following porcine coronary angioplasty
Cardiovasc Res, April 1, 2001; 50(1): 125 - 136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.